Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

International research company Novo Nordisk is investing £115 million in a new research centre at the University of Oxford, as part of a new type 2 diabetes research collaboration with the University.

© Elisa Vergari & Anne Clark